Hāʻawi kēiaʻatikala i kaʻikeʻike i ka mālamaʻana i ka mālamaʻana, prognosis, a me nā mea halihali e hoʻomaʻamaʻa ana i loko Renal Center Carcinoma (RCC). ^. Keʻimi nei mākou i nā koho lapaʻau likeʻole, nā kumuwaiwai e hoʻolauleʻa ana i nā prognosis no ka loaʻaʻana o ka prognosis, a me nā kumuwaiwai no ka loaʻaʻana o ka mālama maikaʻi loa.
Renal Center Carcinoma (RCC) kahiʻano o ke kanesa i hoʻokumu i ka lining o nā pahu liʻiliʻi i loko o ke keiki liʻiliʻi. ʻO nā moʻokāki no kahi hapa nui o nā counter conicer a hiki ke heluʻia i loko o nāʻano likeʻole o nā subtyps i nā kumu o nā kumu kumu. ʻO kaʻike mua a me keʻano loiloi he mea nui no ka hopena maikaʻi loa.
Ua kūʻiaʻo RCC e like me ka nui o ka pālahalahaʻana o ka maʻi maʻi. ʻO ke kūpaʻaʻana he mea maikaʻi loa i ka hoʻoholoʻana i ka hoʻolālā olakino kūpono a me ka wānana prognosis. ʻO nā wahi e pili ana i nā maʻi mai nā maʻi kūloko (Stage I) i ka maʻi metastatic (State IV) ʻO ka hoʻomaopopoʻana i ka'ōnaehana staging he mea nui loa no nā poʻe maʻi a me ko lākou mauʻohana.
ʻO ka hanaʻana he lāʻau lapaʻau maʻamau no ka mea maʻamau rc, e pili pinepine ana i ka laweʻana i ka laweʻana o ka pēpē i hoʻopilikiaʻia Māhele ORRORTOMRY, kahi i laweʻia ai kahi hapa lepo o ka poʻo o ke keiki,ʻo ia kekahi koho i kekahi mau hihia. ʻO ke koho o ka hana e pili ana i kekahi mau kumu, me keʻano o ke kahua a me keʻano o ka tumor.
Ua hoʻolālāʻia nā mea i hoʻopaʻaʻia i nā mea hoʻokūkū hoʻokūkū kūikawā i nā cell cell cell aʻo ka hōʻemiʻana i ka hōʻehaʻana i nā cell olakino. Ua hoʻoikaikaʻia kēia mau hana mālama i ka hoʻokele o RCC,ʻo ka hāʻawiʻana i nā uku ola i hoʻomaikaʻiʻia. Nā hiʻohiʻona e hoʻopili ai i ka lā, pazopanib, a mexitinib. ʻO ke kohoʻana o ka mea i hoʻokumuʻia e pili ana i nāʻano kiko'ī i nā hiʻohiʻona kūikawā o ka Tumor a me ke olakino holoʻokoʻa o ka mea maʻi.
ʻO ka immunotheray harnessses i keʻano o keʻano o ke kino o ke kino e hakakā ai i nā cell cell cell. E nānā i nā mea hoʻonaninani, e like me nivolumamab a me ka ipalimumab ʻO kēia mau lāʻau lapaʻau e hana nei e ka blocking profile e pale i ka'ōnaehana o ka intmune mai ka hoʻoukaʻana i nā cell cell cell. Hiki ke hoʻohanaʻiaʻo immunotherapy a hui pūʻia me nā hana'ē aʻe.
Hoʻohanaʻo Radiation Therapy i ka radiation ikaika kiʻekiʻe e pepehi ai i nā cell cell cell. ʻOiaiʻaʻole he hoʻomaʻamaʻa mua no RCC, e hoʻohanaʻia ma nā kūlana kiko'ī, e like me ka hoʻokeleʻana i nā maʻi maʻamau a iʻole nā hōʻailonaʻana i ka maʻi holomua.
Ua hāʻawiʻia kekahi mau mea i ka prognosis o renal Center Carcinoma, me keʻano o ke kahua o ke kanesa ma ka maʻi maʻi,ʻo ka papa kiʻekiʻe, ke nānāʻana o ka metastasis, a me ke olakino olakino o ka mea maʻi. ʻO kaʻike mua a me ka mālamaʻana i ka hoʻomaʻamaʻa nuiʻana i nā kumukūʻai ola. ʻO ka mālama maʻamau-pono wale nō ka mea mālama i ka nānāʻana no Recurrence a iʻole holomua.
Hānō | Hopena ma ka prognosis |
---|---|
Hana ma ka maʻi maʻi | Loaʻa i nā papa mua ke loaʻa i kahi prognosis maikaʻi aʻe. |
Thior pae | ʻOi aku ka nui o nā mea kiʻekiʻe o nā papa kiʻekiʻe |
Metastasis | ʻO ka heleʻana o ka metastasis i mea nui loa i ka progonosis. |
Ke kohoʻana i kahi haukapila me ka loea i ka mālamaʻana renal Center Carcinoma he mea nui no nā hopena maikaʻi loa. E nānā i nā kikowaena me nā mea i loaʻa i nā mea urologists iʻikeʻia, nā mea hoʻokele, a hoʻolaʻa i nā hui multidisciplinary. E noʻonoʻo i nā haukapila me nā koho lapaʻau holomua, e like me ka mea hoʻokūkū robotic a komo i nā hōʻikeʻepekema. ʻO ka heluheluʻana i nā loiloi a me kaʻimiʻana i nā mea noiʻi mai nāʻoihana olakino e hiki ke kōkua pū kekahi.
No nā mea maʻi eʻimi nei i luna kiʻekiʻe renal Center Carcinoma ka mālamaʻana, Shandong banufa cancer noiʻi noiʻi hāʻawi i ka mālama olakino holomua a me kaʻokiʻana i kaʻenehana. ʻO kā lākou kūpaʻa i ka mālama ponoʻana i ka mālamaʻana iā lākou i kahi koho alakaʻi no keʻano o ka mālama maʻi maʻi.
Hōʻike:ʻO kēiaʻikepili no nā kumu hoʻonaʻauao wale nō aʻaʻole ia he'ōlelo aʻo olakino. E kūkākūkā mau me kahiʻoihana olakino olakino kūpono no ka maʻi maʻi a me ka mālamaʻana i kekahi kūlana olakino.
p>ʻokoʻa>
kino>